TerrAscend Corp. (OTCMKTS:TRSSF) Receives $3.57 Consensus Price Target from Analysts

Shares of TerrAscend Corp. (OTCMKTS:TRSSFGet Rating) have received an average recommendation of “Moderate Buy” from the ten analysts that are presently covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $3.57.

TRSSF has been the topic of several analyst reports. Cantor Fitzgerald dropped their target price on TerrAscend from $2.85 to $2.15 and set a “neutral” rating on the stock in a research report on Friday, October 28th. Cowen dropped their target price on TerrAscend from $9.00 to $4.50 in a research report on Monday, August 15th. Craig Hallum lowered TerrAscend from a “buy” rating to a “hold” rating and dropped their target price for the stock from $7.50 to $2.00 in a research report on Friday, August 12th. Canaccord Genuity Group started coverage on TerrAscend in a report on Monday, September 12th. They set a “buy” rating and a C$4.25 price target on the stock. Finally, Needham & Company LLC lowered their price target on TerrAscend from $4.00 to $3.00 and set a “buy” rating on the stock in a report on Friday, August 12th.

TerrAscend Price Performance

Shares of OTCMKTS TRSSF opened at $1.78 on Tuesday. TerrAscend has a 1-year low of $1.21 and a 1-year high of $6.76. The company has a debt-to-equity ratio of 0.77, a current ratio of 0.66 and a quick ratio of 0.37. The business’s fifty day moving average price is $1.55 and its two-hundred day moving average price is $2.29. The firm has a market capitalization of $448.31 million and a PE ratio of -1.33.

About TerrAscend

(Get Rating)

TerrAscend Corp. cultivates, processes, and sells medical and adult use cannabis in Canada and the United States. It produces and distributes hemp-derived wellness products to retail locations; and manufactures cannabis infused artisan edibles. The company also operates three retail dispensaries under the Apothecarium brand name in California and Pennsylvania.

Featured Stories

Analyst Recommendations for TerrAscend (OTCMKTS:TRSSF)

Receive News & Ratings for TerrAscend Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TerrAscend and related companies with MarketBeat.com's FREE daily email newsletter.